Effect of NGX-4010 on ENFD and Sensory Function
NCT00254449
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Human Volunteers
Interventions
DRUG:
NGX-4010
Sponsor
NeurogesX